Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for vascular inflammation in ankylosing spondylitis
NL-OMON40566Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of atorvastatin in ankylosing spondylitis (AS) and atherosclerosis, sponsored by Amsterdam University Medical Center. Primary endpoint: Change in vessel wall FDG uptake after 3 months of statin therapy. Started Feb 2014; status: active, not recruiting.
02
Drugs
atorvastatin
03
Conditions
ankylosing spondylitis (AS)atherosclerosis
Beyond the preview
Go deeper on NL-OMON40566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40566.